ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 135 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,570,520 | -36.4% | 9,592 | -99.0% | 0.79% | -51.9% |
| Q2 2023 | $10,333,321 | -21.2% | 996,463 | -38.5% | 1.65% | -44.7% |
| Q1 2023 | $13,117,636 | +6206.6% | 1,621,463 | +13274.0% | 2.98% | +10925.9% |
| Q1 2022 | $208,000 | +33.3% | 12,124 | +12.4% | 0.03% | +17.4% |
| Q4 2021 | $156,000 | -79.7% | 10,785 | -74.7% | 0.02% | -57.4% |
| Q3 2021 | $770,000 | -51.2% | 42,712 | -52.4% | 0.05% | -57.5% |
| Q2 2021 | $1,577,000 | -66.7% | 89,788 | -52.3% | 0.13% | -20.6% |
| Q1 2021 | $4,742,000 | +36.7% | 188,200 | -64.9% | 0.16% | +4.6% |
| Q4 2020 | $3,468,000 | – | 535,800 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |